seretide diskus 50/250 micrograms/dose of powder for inhalation in doses
ecosse limited “mangion building”, new street off valletta road, luqa, lqa 6000, malta - salmeterol xinafoate, fluticasone propionate - inhalation powder, pre-dispensed - salmeterol xinafoate 50 µg fluticasone propionate 250 µg - drugs for obstructive airway diseases
bemrist breezhaler
novartis europharm limited - indacaterol, mometasone furoate - asthma - drugs for obstructive airway diseases, - bemrist breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
airflusal forspiro 50 microgram/250 microgram/dose, inhalation powder, predispensed
rowex ltd newtown bantry, co. cork, , ireland - salmeterol xinafoate, fluticasone furoate - inhalation powder, pre-dispensed - salmeterol xinafoate 50 µg fluticasone furoate 250 µg - drugs for obstructive airway diseases
airflusal forspiro 50 microgram/500 microgram/dose, inhalation powder, predispensed
rowex ltd newtown bantry, co. cork, , ireland - salmeterol xinafoate, fluticasone furoate - inhalation powder, pre-dispensed - salmeterol xinafoate 50 µg fluticasone furoate 500 µg - drugs for obstructive airway diseases
seretide 250 diskus 50 microgram/250 microgram/dose inhalation powder, pre-dispensed
nm pharma limited 3/4, cantrija complex triq it-targa, il-maghtab naxxar nxr 6613 , malta - salmeterol xinafoate, fluticasone propionate - inhalation powder, pre-dispensed - salmeterol xinafoate 50 µg fluticasone propionate 100,250 or 500 µg - drugs for obstructive airway diseases
seretide 500 diskus 50 microgram/500 microgram/dose inhalation powder, pre-dispensed
nm pharma limited 3/4, cantrija complex triq it-targa, il-maghtab naxxar nxr 6613 , malta - salmeterol xinafoate, fluticasone propionate - inhalation powder, pre-dispensed - salmeterol xinafoate 50 µg fluticasone propionate 100,250 or 500 µg - drugs for obstructive airway diseases
seretide diskus 50 microgram/500 microgram/ dose inhalation powder, pre-dispensed
neofarma pharmaceuticals limited 42-46, mill street, qormi, qrm 3105, malta - salmeterol xinafoate, fluticasone propionate - inhalation powder, pre-dispensed - salmeterol xinafoate 50 µg fluticasone propionate 500 µg - drugs for obstructive airway diseases
sirdupla 25 microgram/125 microgram per metered dose pressurised inhalation, suspension
viatris limited - salmeterol xinafoate; fluticasone propionate - pressurised inhalation, suspension - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salmeterol and fluticasone
sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation, suspension
viatris limited - salmeterol xinafoate; fluticasone propionate - pressurised inhalation, suspension - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salmeterol and fluticasone
flusalmer s.k. 50250 mcg
k.s.kim international (sk- pharma) ltd., israel - fluticasone propionate; salmeterol as xinafoate - powder for inhalation - salmeterol as xinafoate 50 mcg; fluticasone propionate 250 mcg - salmeterol and other drugs for obstructive airway diseases - flusalmer sk is indicated in the regular treatment of asthma in children and adults, where use of a combination (bronchodilator and inhaled corticosteroid) has been found to be appropriate . flusalmer sk is indicated for the symptomatic treatment of patients with copd, with a fev1 <60% predicted normal (pre-bronchodilator) and a history of repeated exacerbations, who havesignificant symptoms despite regular bronchodilator therapy.